TherapeuticsMD | TXMD - Operating Profit


TherapeuticsMD reported $-1.18M in Operating Profit for its fiscal quarter ending in June of 2024.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD 56.04M 63.93M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Novo Nordisk DKK 5.18B 33.61B Jun/2025
Pfizer USD 4.65B 3.99B Dec/2025
TherapeuticsMD USD -1.18M 40K Jun/2024